Small pancreatic neuroendocrine tumors: Resect or enucleate?

Joal D Beane1, Jeffrey D Borrebach2, Andrew Billderback2

  • 1The Ohio State University Wexner Medical Center, Columbus, OH, USA.

American Journal of Surgery
|December 15, 2020
PubMed
Abstract

Insights

Enucleation is a less invasive surgical option for small pancreatic neuroendocrine tumors (PNETs), showing reduced operative time, fewer transfusions, and lower morbidity compared to resection.

Area of Science:

  • Surgical Oncology
  • Gastroenterology
  • Endocrinology

Background:

  • Small pancreatic neuroendocrine tumors (PNETs) require careful surgical consideration.
  • Comparing surgical approaches is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To compare the postoperative outcomes of resection versus enucleation for small PNETs.
  • To evaluate the safety and efficacy of each surgical technique.

Main Methods:

  • Analysis of the 2014-2017 American College of Surgeons-NSQIP dataset.
  • Comparison of patients undergoing pancreatoduodenectomy or distal pancreatectomy with those who underwent enucleation for small, nonfunctional PNETs (T1/T2).

Main Results:

  • Enucleation was associated with significantly shorter operative times (170 vs. 261 minutes) and fewer transfusions (1.6% vs. 6.7%).
  • Morbidity was lower in the enucleation group (36.2% vs. 48.7%), with no difference in pancreatic fistulas.
  • Postoperative length of stay was shorter after enucleation (5.7 vs. 7.2 days), and mortality was lower (0% vs. 1.5%).

Conclusions:

  • Enucleation, though performed in only 11% of cases, offers significant advantages over resection for small PNETs.
  • Enucleation leads to reduced operative time, fewer transfusions, decreased morbidity, and shorter hospital stays.
  • These findings suggest enucleation as a favorable surgical option for select small PNETs.